Le monde traverse actuellement une période extrêmement stressante à cause de la pandémie du COVID-19. Cette situation exceptionnelle et alarmante pourrait augmenter l’incidence des problèmes de santé mentale, parmi lesquels les troubles psychotiques aigus. Notre observation rapporte deux cas de patients présentant un accès psychotique aigu, avec une thématique délirante en relation avec la pandémie du coronavirus. Les deux patients, qui ne présentaient pas d’antécédents antérieurs de troubles psychiatriques, ont été hospitalisés dans notre service de psychiatrie, après le début du confinement sanitaire obligatoire dans notre pays. La symptomatologie clinique retrouvée était surtout faite d’un syndrome hallucinatoire et d’un syndrome délirant à thématique religieuse, avec des idées délirantes centrées sur le COVID-19. Ce rapport de cas suggère qu’un stress psychosocial intense, provoqué par la crise mondiale actuelle et les mesures de confinement, pourrait constituer un facteur déclenchant de premiers épisodes psychotiques, et avoir un impact sur l’expression clinique et délirante de la psychose aiguë.
BackgroundRecent studies on nursing and medical students showed a higher prevalence of depression and stress than the general population. Religiosity and spirituality are common in Muslim countries and are usually used as a means of coping strategy for psychological and mental disorders.ObjectiveOur objective was to evaluate the association between religious actions, depressive symptoms, and stress among students of nursing education lasting 3 years and students from the first 3 years of medical education lasting 7 years. The study was conducted at Ibn Zohr University of Agadir, Morocco.MethodA sample of different stages of nursing and medical students was recruited. Religiosity was assessed by Muslim Belief into Action (M.BIAC) scale. The depressive symptoms and stress were, respectively, assessed by the Beck Depression Inventory (BDI-II) and Perceived Stress Scale (PSS).ResultsFour hundred and thirteen students participated in this study. Our results showed a high prevalence of depressive symptoms (62.2%) and stress (66.8%). The depression scores were higher in the following subsample categories: students in the first 2 years of studies, female medical students, and nursing students with significant differences. The recorded religiosity was greater among students without depression compared to students with depression (p < 0.001). In the multivariate regression, the BIAC score demonstrated religiosity as neither a risk factor nor a protective factor of depression.ConclusionReligiosity constitutes a protective factor of depression and stress among nursing and medical students. This should improve the student's ability to cope with stressful situations during their training. Prospective studies are needed to further investigate this association and how religiosity improves mental health. This would contribute to improved academic performance and wellbeing among medical and nursing students.
Background Several studies have been conducted on the impact of the COVID-19 pandemic on the general population, but few have examined the longitudinal evolution of psychopathology in patients with mental health disorders at different stages of the pandemic. This study sought to answer these questions by assessing the trajectory of mental health in patients with pre-existing panic disorder in a COVID-19 pandemic setting while evaluating socio-demographic and clinical factors associated with outcomes. Methods This was a longitudinal study of panic disorder patients followed during three waves of the COVID-19 pandemic. Change assessed in mental health status used five validated scales: the Beck Depression Inventory-II (BDI-II), the Beck Anxiety Inventory (BAI), the Impact of Event Scale-revised (IES-R), The Mini International Neuropsychiatric Interview (MINI) for suicidal risk and the Panic Disorder Severity Scale Self Report version (PDSS-SR). Predictors of mental health symptom progression were assessed using multivariate analysis. Results There was a significant wave-to-wave reduction in depressive symptoms, post-traumatic stress, panic disorder severity and suicidal risk. Concerning anxiety symptoms, patients felt better and better during successive waves of the pandemic, with a statistically significant decrease from the first to the second wave of the COVID-19 pandemic. The analytical strategy also enabled the identification of the various socio-demographic and clinical factors likely to be associated with higher panic disorder severity. Conclusion It is timely to raise a series of questions that this research attempts to answer, and to develop personalized strategies for future pandemics in order to minimize the risk of aggravation or relapse in patients with panic disorder in particular, who may be more sensitive to multiple aspects of the pandemic.
Background: COVID-19 virus outbreak appeared in December 2019 and was announced as pandemic by the World Health Organization (WHO) in March 2020. Recent cases of reactive psychosis in the context of the COVID-19 pandemic have been reported. However, there was reduced interest attributed to cases of acute psychosis affecting patients with COVID-19. In here, we present a clinical case of a female patient who showed a brief psychotic disorder during a symptomatic infection with COVID-19. Methods: We discuss the differential diagnosis of brief psychotic disorder with marked stressor and neuropsychiatric symptoms of COVID-19 infection. Although the stress factor appeared to be linked to the acute psychosis onset in our COVID-19 positive patient, the diagnosis of a psychotic disorder due to the viral coronavirus infection is worthing to be reported and discussed. Results and Conclusion: The stress factor appears to be linked to the onset of acute psychosis in this COVID-19 positive patient, the diagnosis of a psychotic disorder due to the viral coronavirus infection is worth to be mentioned. Thus, we suggest that a new psychosis case associated with COVID-19 infection due to potential immune-mediated neuropathogenesis that would justify further investigation. Through this case report, we highlight the need for vigilant monitoring of neuropsychiatric symptoms in individuals with COVID-19 infections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.